Adaptimmune Therapeutics Plc EV/EBIT
Cos'è EV/EBIT di Adaptimmune Therapeutics Plc?
EV/EBIT di Adaptimmune Therapeutics Plc è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Adaptimmune Therapeutics Plc
Cosa fa Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Aziende con ev/ebit simili a Adaptimmune Therapeutics Plc
- Progenics Pharmaceuticals ha EV/EBIT di N/A
- TUI AG ha EV/EBIT di N/A
- Endo International plc ha EV/EBIT di N/A
- McNally Bharat Engineering ha EV/EBIT di N/A
- Inca One Gold ha EV/EBIT di N/A
- NGX International ha EV/EBIT di N/A
- Adaptimmune Therapeutics Plc ha EV/EBIT di N/A
- Capitol Federal ha EV/EBIT di N/A
- Antibe Therapeutics ha EV/EBIT di N/A
- Paramount Gold Nevada Corp ha EV/EBIT di N/A
- Qualtrics International ha EV/EBIT di N/A
- Optical Cable ha EV/EBIT di N/A
- Trail Blazer Capital Corp ha EV/EBIT di N/A